The Board of Directors of Krishna Institute of Medical Sciences (KIMS) is scheduled to meet on Friday, February 06, 2026, to consider and approve the unaudited financial results for the Q3 (Oct-Dec) quarter and nine-month period ended December 31, 2025. The trading window for company’s equity shares has been closed from January 01, 2026, and will reopen 48 hours after the results are made public.
Board Meeting Announcement
A meeting of the Board of Directors of Krishna Institute of Medical Sciences (KIMS) has been scheduled to take place on Friday, February 06, 2026. The primary agenda is to review and approve the company’s financial performance.
Financial Results on the Agenda
During the meeting, the Board will specifically consider and approve the unaudited financial results, both on a standalone and consolidated basis, for the Q3 (Oct-Dec) quarter and nine-month period which concluded on December 31, 2025.
Trading Window Closure
In accordance with the Company’s insider trading policies, the trading window for dealing in the Company’s equity shares has been closed for designated persons. This closure began on January 01, 2026, and will remain in effect until 48 hours after the financial results are officially disclosed to the public.
Source: BSE
